In the First Study of Its Kind Psilocybin Reduces Depression in Veterans
This is the first study to show that psilocybin reduces depression in veterans. Hopefully this is a sign of more
Read More
This is the first study to show that psilocybin reduces depression in veterans. Hopefully this is a sign of more
Read More
A new study suggests that we could be getting closer to personalized ketamine therapies to treat depression and other issues.
Read More
This decision has significant legal implications, particularly for future cases involving psychedelic substances like magic mushrooms.
Read More
As conventional treatments reach their limits for people with advanced cancer, a growing number are turning to psychedelic-assisted therapy.
Read More
Classic psychedelics like psilocybin and LSD may help people quit cigarettes, but researchers caution that evidence remains preliminary.
Read More
The psychedelic drugs market is poised for explosive growth, with projections going from $3.63 billion in 2024 to $10.11 billion
Read More
Bryan Johnson, the biohacking entrepreneur known for his extreme anti-aging protocols, said he will test psilocybin as a longevity therapy.
Read More
Federal officials are signaling growing momentum behind psychedelic drug development. The flood of applications reflects broad enthusiasm.
Read More
A new PET imaging study provides the first direct evidence that ketamine normalizes AMPA receptor density in the brains of
Read More
Researchers combined more than 500 scans and found that psychedelics all pushed the brain toward a similar pattern of activity.
Read More